Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer

Clinical trial NCT00590902 · COMPLETED

Trial details

NCT number: NCT00590902
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer

Start date: 2002-03-01
Primary completion: 2013-02-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.